Climacteric obesity: from genesis to clinic

References

• Stein J C, Colditz A G. The epidemic of obesity. J Clin Endocrinol Metab 2004; 89: 2522–2525
   PubMed Web of Science ®Google Scholar
• Bray A G. Medical consequences of obesity. J Clin Endocrinol Metab 2004; 89: 2583–2589
   PubMed Web of Science ®Google Scholar
• Groundy M S. Obesity, metabolic syndrome and cardiovascular disease. J Clin Endocrinol Metab 2004; 89: 2595–2600
   PubMed Web of Science ®Google Scholar
• Zimmet P, Alberti G, Shaw J. A new IDF worldwide definition of the metabolic syndrome: the rationale and the results. Diabetes Voice 2005; 50: 31–33
   Google Scholar
• Karelis A D, St-Pierre D H, Conus F, Rabasa-Lhoret R, Poehlman E T. Metabolic and body composition factors in subgroups of obesity: what do we know?. J Clin Endocrinol Metab 2004; 89: 2569–2575
   PubMed Web of Science ®Google Scholar
• Conus F, Allison D B, Rabasa-Lhoret R, St-Onge M, St-Pierre D H, Tremblay-Lebeau A, Poehlman E T. Metabolic and behavioral characteristics of metabolically obese but normal weight women. J Clin Endocrinol Metab 2004; 89: 5013–5020
   PubMed Web of Science ®Google Scholar
• Dvorak R V, DeNino W F, Ades P A, Poehlman E T. Phenotypic characteristic associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 1999; 48: 2210–2214
   PubMed Web of Science ®Google Scholar
• Sims E A. Are the persons who are obese, but metabolically healthy?. Metabolism 2002; 50: 1499–1504
   Web of Science ®Google Scholar
• You T, Ryan A S, Nicklas B J. The metabolic syndrome in obese postmenopausal women relationship to body composition, visceral fat and inflammation. J Clin Endocrinol Metab 2004; 89: 5517–5522
   PubMed Web of Science ®Google Scholar
• Park Y W, Zhu S, Palaniappan L, Heshka S, Carnethon M R, Heymsfield S B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from Third National Heath and Nutrition Examination Survey 1988–1994. Arch Intern Med 2003; 163: 427–436
   PubMed Web of Science ®Google Scholar
• Tchernof A, Desmeules A, Richard C, Laberge P, Daris M, Mailloux J, Rheaume C, Dupont P. Ovarian hormone status and abdominal visceral adipose tissue metabolism. J Clin Endocrinol Metab 2004; 89: 3425–3430
   PubMed Web of Science ®Google Scholar
• Brochu M, Tchernof A, Dionne I J, Sites C K, Eltabbakh G H, Sims E A, Poehlman E T. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?. J Clin Endocrinol Metab 2001; 86: 1020–1025
   PubMed Web of Science ®Google Scholar
• Dubnov G, Brzezinski A, Berry E. Weight control and management of obesity after menopause: the role of physical activity. Maturitas 2003; 44: 89–101
   PubMed Web of Science ®Google Scholar
• Nadel I, Cypryk K, Pertynski T, Sobczuk A, Stetkiewicz T. Studies on the incidence and clinical significance of the metabolic syndrome in postmenopausal women in Lodz region. Pol Arch Med Wewn 2001; 106: 823–828
   PubMedGoogle Scholar
• Lopatynski J, Tokarski S, Mardarowicz G, Niewidziol M. Morbidity in adult rural population in Lublin region. Ann Univ Mariae Curie Sklodowska [Med] 1999; 53(Suppl 5)156–160
   Google Scholar
• Milewicz A, Jedrzejuk D, Lwow F, Bialynicka A S, Lopatynski J, Mardarowicz G, Zahorska-Markiewicz B. Prevalence of obesity in Poland. Obes Rev 2005; 6: 113–114
   PubMed Web of Science ®Google Scholar
• Pasquali R, Casimirri F, Labate A, Tortelli O, Pascal G, Anconetani B, Gatto M R, Flamia R, Capelli M, Barbara L. Body weight, fat distribution and the menopausal status in women. The VMH Collaborative Group. Int J Obes Relat Metab Disord 1994; 18: 614–621
   PubMed Web of Science ®Google Scholar
• Milewicz A, Bidzinska B, Sidorowicz A. Perimenopausal obesity. Gynecol Endocrinol 1996; 10: 285–291
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Ciaponi M, Cappagli B. Climacteric modifications in body weight and fat distribution. Climacteric 1999; 2: 37–44
   PubMedGoogle Scholar
• Milewicz A, Tworowska U, Demissie M. Menopausal obesity – myth or fact?. Climacteric 2001; 4: 273–283
   PubMedGoogle Scholar
• Matthews K A, Abrams B, Crawford S, Miles T, Neer R, Powell L H, Wesley D. Body mass index in mid-life women: relative influence of menopause, hormone use and ethnicity. Int J Obes Relat Metab Disord 2001; 25: 863–873
   PubMed Web of Science ®Google Scholar
• Ferrara C M, Lynch N A, Nicklas B J, Ryan A S, Berman D M. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab 2002; 87: 4166–4170
   PubMed Web of Science ®Google Scholar
• Poehlman E T. Menopause, energy expenditure and body composition. Acta Obstet Gynecol Scand 2002; 81: 603–611
   PubMed Web of Science ®Google Scholar
• Eriksson P, Dahlman I, Ryden M, Hoffstedt J, Arner P. Relationship between β-2 adrenoreceptor gene haplotypes and adipocyte lipolisis in women. Int J Obes Relat Metab Disord 2004; 28: 185–190
   PubMed Web of Science ®Google Scholar
• Mattevi V S, Zembrzuski V M, Hutz M H. A resistin gene polymorphism is associated with body mass index in women. Hum Genet 2004; 115: 208–212
   PubMed Web of Science ®Google Scholar
• Malacara J M, Perez-Luque E L, Martinez-Garza S, Sanchez-Marin F J. The relationship of estrogen receptor α polymorphism with symptoms and other characteristics in postmenopausal women. Maturitas 2004; 49: 163–169
   PubMed Web of Science ®Google Scholar
• Schuit S C, van Meurs J B, Bergink A P, van der Klift M, Fang Y, Leusink G, Hofman A, van Leeuwen J P, Uitterlinden A G, Pols H A. Weight in pre- and postmenopausal women is influenced by estrogen receptor α gene polymorphism. J Clin Endocrinol Metab 2004; 89: 303–309
   PubMed Web of Science ®Google Scholar
• Deng H W, Li J, Li J L, Dowd R, Davies K M, Johnson M, Gong G, Deng H, Recker R R. Association of estrogen receptor α genotypes with body mass index in normal healthy postmenopausal Caucasian women. J Clin Endocrinol Metab 2000; 85: 2748–2751
   PubMed Web of Science ®Google Scholar
• Giusti V, Suter M, Verdumo C, Gaillard R C, Burckhardt P, Pralong F P. Molecular determinants of human adipose tissue: differences between visceral and subcutaneous compartments in obese women. J Clin Endocrinol Metab 2004; 89: 1379–1384
   PubMed Web of Science ®Google Scholar
• Freedland E S. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond) 2004; 5: 12
   Google Scholar
• Wajchenberg B L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697–738
   PubMed Web of Science ®Google Scholar
• Mayes J S, Watson G H. Direct effects of sex hormones on adipose tissues and obesity. Obes Rev 2004; 5: 197–216
   PubMedGoogle Scholar
• Randolph J F, Jr, Sowers M, Gold E B, Mohr B A, Luborsky J, Santoro N, McConnell D S, Finkelstein J S, Korenman S G, Matthews K A, et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size and menopausal status. J Clin Endocrinol Metab 2003; 88: 1516–1522
   PubMed Web of Science ®Google Scholar
• dos Reis C M, de Melo N R, Meirelles E S, Vezozzo D P, Halpern A. Body composition, visceral fat distribution and fat oxidation in postmenopausal women using oral and transdermal estrogen. Maturitas 2003; 46: 59–68
   PubMed Web of Science ®Google Scholar
• Schimizu H, Shimomura Y, Nakanishi Y. Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol 1997; 154: 285–292
   PubMed Web of Science ®Google Scholar
• Rosenbaum M, Nicolson M, Hirsh J. Effects of gender, body composition and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996; 81: 3224–3427
   Web of Science ®Google Scholar
• Milewicz A, Bidzinska B, Mikulski E, Demissie M, Tworowska U. Influence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels. Gynecol Endocrinol 2000; 14: 196–203
   PubMed Web of Science ®Google Scholar
• Howard B V, Adams-Campbell L, Allen C, Black H, Passaro M, Rodabough R J, Rodriguez B L, Safford M, Stevens V J, Wagenknecht L E. Insulin resistance and weight gain in postmenopausal women of diverse ethnic groups. Int J Obes Relat Metab Disord 2004; 28: 1039–1047
   PubMedGoogle Scholar
• Franco C, Brandberg J, Lonn L, Andersson B, Bengtsson B A, Johannsson G. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: 12 months placebo-controlled trial. J Clin Endocrinol Metab 2005; 90: 1466–1474
   PubMed Web of Science ®Google Scholar
• MacEven E G, Kurzman I D. Obesity in the dog: role of the adrenal steroid dehydroepiandrosterone (DHEA). J Nutr 1991; 121: 51–55
   Web of Science ®Google Scholar
• Coleman D L, Leiter E H, Schweizer R W. Therapeutics effects of dehydroepiandrosterone in diabetic mice. Diabetes 1982; 31: 830–833
   PubMed Web of Science ®Google Scholar
• Bednarek-Tupikowska G, Milewicz A, Kossowska B, Bohdanowicz-Pawlak A, Sciborski R. The influence of DHEA on serum lipids, insulin and sex hormone levels in rabbits with induced hypercholesterolemia. Gynecol Endocrinol 1995; 9: 23–28
   PubMed Web of Science ®Google Scholar
• Morales A J, Nolan J J, Nelson J C. Effects of replacement doses of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994; 78: 1360–1367
   PubMed Web of Science ®Google Scholar
• Milewicz A, Jedrzejuk D, Bohdanowicz-Pawlak A, Medras M. Metabolic and hormonal changes after DHEA treatment. The 9th International Menopause Society world congress on the menopause, Yokohama (Japan), T Aso, T Yanairharia, Y Taketani. Moduzzi Editore, Bologna 1999; 215–220
   Google Scholar
• Jedrzejuk D, Medras M, Milewicz A, Demissie M. Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: effects on fat distribution, insulin sensitivity and lipid metabolism. Aging Male 2003; 6: 2–6
   Google Scholar
• Matsukawa T, Sugiyama Y, Watanabe T. Gender difference in age-related changes in muscle sympathetic nerve activity in healthy subjects. Am J Physiol 1998; 275: R1600–R1604
   PubMed Web of Science ®Google Scholar
• Jones P P, Davy K P, Alexander S. Age-related increase in muscle sympathetic nerve activity is associated with abdominal adiposity. Am J Physiol 1997; 272: E976–E980
   PubMed Web of Science ®Google Scholar
• Acheson K J, Ravussin E, Schoeller D A, Christin L, Bourquin L, Baertschi P, Danforth E, Jr, Jequier E. Two-week stimulation or blockade of the sympathetic nervous system in man: influence on body weight, body composition and twenty four-hour energy expenditure. Metabolism 1988; 37: 91–98
   PubMed Web of Science ®Google Scholar
• Spraul M, Ravussin E, Fontvieille A M. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 1993; 92: 1730–1735
   PubMed Web of Science ®Google Scholar
• Ryan A S, Nicklas B J. Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care 2004; 27: 1699–1705
   PubMed Web of Science ®Google Scholar
• Milewicz A, Demissie M, Zatonska K, Jedrzejuk D, Tworowska U, Ilow R, Biernat J. Influence of dietary and genetic factors on metabolic status in obese and lean postmenopausal women. Gynecol Endocrinol 2003; 17: 333–338
   PubMed Web of Science ®Google Scholar
• Milewicz A, Horst-Sikorska W, Zatonska K, Jedrzejuk D, Demissie M, Bolanowski M. Selected cytokines and growth factors and obesity on postmenopausal women. Gynecol Endocrinol 2001; 15(Suppl.5)10
   Google Scholar
• Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe D M, Papadiamantis Y, Markopoulos C, Spanos E, Chrousos G, et al. Adiponectin and breast cancer. J Clin Endocrinol Metab 2004; 89: 1102–1107
   PubMed Web of Science ®Google Scholar
• Dal Maso L, Augustin L S, Karalis A, Talamini R, Franceschi S, Trichopoulos D, Mantzoros C S, La Vecchia C. Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 2004; 89: 1160–1163
   PubMed Web of Science ®Google Scholar
• The IMS Executive Committee. Guidelines for hormone treatment of women in the menopausal transition and beyond. Maturitas 2005; 51: 15–21
   PubMed Web of Science ®Google Scholar
• Barlow D H. Menopause and HRT – the state of the art in Europe. Maturitas 2005; 51: 40–48
   PubMed Web of Science ®Google Scholar